Health Care ETFs Compared: XLV vs. FHLC Holdings and Performance
What happened
A comparison of the Health Care Select Sector SPDR ETF (XLV) and the Fidelity MSCI Health Care Index ETF (FHLC) was released. XLV tracks the S&P 500 health care companies and holds $43.62 billion in assets. FHLC tracks the MSCI USA IMI Health Care Index and holds $3.60 billion.
From aol.com
Why it matters
XLV includes 65 positions, while FHLC includes 337, giving FHLC broader exposure to small and mid-size companies. Eli Lilly and Johnson & Johnson account for 27% of XLV but only 22% of FHLC. Over five years, XLV outperformed FHLC, achieving a 49% return compared to 42% for FHLC.
From aol.com
Who's involved
- Eli Lilly and CompanyMajor holding in both XLV and FHLC
- Johnson & JohnsonMajor holding in both XLV and FHLC
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.Keep exploring
The entities involved
-
CRISPR Therapeutics
company in Basel, Switzerland
Nothing else this week.
-
Eli Lilly and Company
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Related events
- CRISPR Therapeutics formed a strategic partnership with Vertex Pharmaceuticals.
- CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.
- CRISPR Therapeutics announced that A.J. Silver will succeed Raju Prasad as CFO, following Silver's time at Ernst & Young LLP.